The neural regulation of organs can be categorized as systemic or local. Whereas systemic regulation by the hypothalamus-pituitary-adrenal gland-mediated release of steroid hormones has been well studied, the mechanisms for local regulation have only recently emerged. Two types of local neural regulation are known, the gateway reflex and the inflammatory reflex. The gateway reflex describes a mechanism that converts regional neural stimulations into inflammatory outputs by changing the state of specific blood vessels. Molecularly, the enhancement of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity in endothelial cells by neurotransmitters, such as noradrenaline and ATP, induces an enhanced production of pro-inflammatory mediators, including chemokines, which form immune cell gateways at specific vessels. Several types of gateway reflex have been identified, and each regulates distinct organs by creating gateways for autoreactive T cells that induce local inflammation. On the other hand, the inflammatory reflex elicits an anti-inflammatory response through vagal nerves. Here, we summarize recent works on these two local neuro-immune interactions, giving special focus to the gateway reflex.
Introduction
All living organisms are exposed to environmental stimulations such as temperature, light, sound and gravity. These stimuli are sensed by the nervous system. In addition to these environmental stimuli, physical and biological changes in our body, including mental stresses, pain, aging, weight, disease and infection, can be sensed by specific neural pathways. These pathways distribute to every organ in the body, suggesting that organ homeostasis is regulated by specific neural pathways. There are two major neuro-immune systems. One is well-known systemic responses via the hypothalamus-pituitary-adrenal axis (1) , and the other is local neuro-immune interactions mediated by specific neural activations. We and others have revealed these specific neural pathways that control local immune responses. In this review article, we highlight recent works on these regional neuro-immune interactions, including the gateway reflex and inflammatory reflex. These pathways hold promise for the development of novel therapeutic strategies. Because there are many good reviews about the inflammatory reflex (2-7), we devote most of our attention to the gateway reflex.
Gravity is a positive regulator of local inflammation
Gravity stimulates all land animals. Gravity stimulation maintains physical functions such as muscle strength and bone mass (8, 9) . Some astronauts after flight have experienced ophthalmic changes including optic disc edema, which is indicative of endothelial dysfunction and is related to inflammatory symptoms. Possible mechanisms for these effects are a shift of cerebrospinal fluid or increased cranial pressure under micro-gravity (10, 11) . However, the direct contribution of gravity stimulation to local inflammation is not fully understood.
We found a new role of gravity in the course of our study about chronic inflammation. Using animal disease models for inflammatory diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA), we found that non-immune cells including endothelial cells and fibroblasts have an essential role in the induction of inflammatory responses (12, 13) . These non-immune cells produce large amounts of pro-inflammatory mediators, such as chemokines, cytokines and growth factors, upon the simultaneous activation of two transcription factors, NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) and STAT3 (signal transducer and activator of transcription 3). The co-activation of NF-κB and STAT3 synergistically activates NF-κB to enhance the production of pro-inflammatory factors, stimulating the pathogenesis of multiple chronic inflammation animal models for RA (12) (13) (14) (15) (16) , experimental autoimmune encephalomyelitis (EAE), which is a model of MS (12, 17, 18) , and allogeneic transplantation (19) . We named the synergistic effect of NF-κB and STAT3 the inflammation amplifier (20, 21) .
During the course of these studies, we considered where and how autoreactive CD4 + T cells in the blood initially invade the central nervous system (CNS) during EAE, because CNS inflammation occurs despite the blood-brain barrier (BBB), which should prevent the entry of large molecules and cells in blood such as immune cells to the CNS. To investigate, we selected an adoptive-transfer EAE mouse model, in which CNS inflammation can be induced by a single intravenous injection of autoreactive, pathogenic CD4 + T cells against myelin oligodendrocyte glycoprotein (22) . This model can be induced without Freund's complete adjuvant and toxin, which could otherwise affect the migration of immune cells by eliciting systemic inflammation and chronic pain. At a preclinical stage of EAE, whole-mount sectioning of recipient mice and subsequent flow cytometry analysis revealed that pathogenic CD4 + T cells exclusively located at the dorsal vessels of the fifth lumbar (L5) spinal cord (17) . Consistent with this finding, many chemokines including CCL20, a chemokine that attracts IL-17-secreting CD4 + T (T h 17) cells, which are essential for the pathogenesis of EAE (23, 24) , were up-regulated at the L5 dorsal vessels compared with other dorsal vessels of the spinal cord (17) . This preferential accumulation of pathogenic CD4 + T cells at L5 was not observed with the conditional deletion of STAT3 in non-immune cells such as endothelial cells, indicating that the up-regulation of chemokines at the L5 vessels was dependent on the inflammation amplifier (20, 21) . Therefore, the L5 dorsal vessels are the first breach point of the BBB for pathogenic CD4 + T cells in the transfer EAE model (Fig. 1) . We also found that the L5 region is severely damaged in an active immunization EAE model in mice (unpublished data by Masaaki Murakami), although we do not exclude a possibility that other areas such as the choroid plexus in the brain are also concomitantly affected in this model, as reported previously (25) . On the other hand, preferential demyelination in the L5 region at very early stage of MS in humans remains to be elucidated. Unlike our EAE model, which typically shows a loss of tonicity of the tail tip as a first sign, MS patients have heterogeneous clinical presentations including visual disturbances, motor impairments, pain and/or cognitive deficits (26) , suggesting neuroinflammation in various sites of the CNS. As discussed in detail below, because specific local immune interactions define the first breach point of the BBB by immune cells in our EAE model, we hypothesize that compared to mice, humans have abilities for more social interactions and sophisticated movements, which may induce patients' specific neural activations to form respective BBB breaching points.
We investigated how these cells accumulate at the L5 cord and found that a neuro-immune interaction explains the selective accumulation. The L5 dorsal root ganglion (DRG) is the largest of DRGs in both human and mice, partly because the L5 DRG contains neurons that connect to the soleus muscles, the main anti-gravity muscles, and are constantly activated by gravity (27, 28) . The tail-suspension assay, a ground experiment employed by the National Aeronautics and Space Administration (NASA) that releases the hindlegs from gravity burden by tail suspension (29) , abrogated the selective accumulation of immune cells at L5 in EAE mice (17) . Consistently, the tail suspension significantly decreased the expression of chemokine levels in the L5 vessels, and instead up-regulated them in the cervical vessels because of an increased gravity burden on the forelegs. When the soleus muscles were electrically stimulated during the tail suspension, the expression of chemokines was restored in the L5 vessels. Furthermore, electric stimulation to other muscles, Fig. 1 . Gravity gateway reflex. Gravity stimulates the soleus muscles to activate sensory nerves whose cell bodies are located at the DRG of the fifth lumbar (L5) spinal cord. Neural signals to the L5 DRG neurons transmit to the L5 sympathetic ganglion, followed by NE secretion at the L5 dorsal vessels. Although anatomical or electrophysiological evidence for neural connections between neurons in the L5 DRG and L5 sympathetic ganglions remains to be established, these experimental data suggest their functional connection. NE enhances the inflammation amplifier to up-regulate chemokine expression in the L5 dorsal vessels, causing the recruitment of pathogenic CD4 + T cells.
including quadriceps and triceps, induced an up-regulation of chemokines at the specific dorsal vessels of the spinal levels corresponding to the site of the stimulation (17) . These results indicated that activation of a specific sensory pathway enhances chemokine expression at specific vessels. Furthermore, we found that nerves in the sympathetic ganglions were more activated at the L5 level than the L1 level and that chemical blockade of adrenergic receptors inhibited chemokine expression at L5 and lowered EAE clinical stores. Although anatomical or electrophysiological evidence for neural connections between neurons in the L5 DRG and L5 sympathetic ganglions remains to be established, these experimental data suggest their functional connection. On the basis of these observations, we concluded that a specific regional sensory-sympathetic nerve interaction from the soleus muscles creates the initial gateway for immune cells to enter the CNS at the L5 level ( Fig. 1 ) (17). These results revealed a novel neuro-immune interaction, where regional neural activation regulates the blood vessels to secrete chemokines, creating the gateway for immune cells to enter and locally accumulate. This phenomenon is now called the gateway reflex (3, (5) (6) (7) (30) (31) (32) (33) (34) .
The gateway reflex can be controlled by electric stimulation. Weak electric pulses to the quadriceps, whose sensory neurons connect to L3 DRG, induced chemokine expression at the L3 dorsal vessels, and those to the triceps, whose sensory pathway connects to the DRGs of the lower cervical to upper thoracic levels, induced chemokine expression at the dorsal vessels of the respective spinal cord levels ( Fig. 2 ) (17) . This electric gateway reflex may be utilized as a therapeutic option or drug delivery to enhance an immune reaction against tumor cells, for example.
Pain sensation can trigger pathology
Because gravity and electric stimulations create specific blood vessel gateways for immune cells at different locations of the CNS, we tested other neural stimulations to extend the gateway reflex. We chose pain sensation as another neural input, because pain sensation causes a tonic sensory stimulation (35, 36) and is a common unwanted symptom that significantly compromises the quality of life of patients with various diseases and injuries (37) . A positive correlation between disease symptoms and pain sensation is reported in MS patients (38) (39) (40) , and a change in pain sensitivity is also reported during EAE (41) .
The trigeminal nerves are composed of three main branches, with the middle branch known to contain sensory nerves exclusively. We performed a partial ligation of the middle branch of the trigeminal nerves to induce pain sensation at the same day of pathogenic CD4 + T cell transfer and found that the pain sensation prolonged the EAE disease symptom (42) . The transfer EAE model we used shows only transient paralysis that never relapses under normal rearing (22, 42) . However, the induction of pain during a remission phase of the transfer EAE clearly caused relapse of the disease. Because pain-mediated relapse was also transient, and the mice under the remission phase even with the nerve ligation tolerated the pain, we hypothesized that the sensitivity to pain might have different phenotypes in MS patients and the EAE model. Indeed, the injection of capsaicin, which activates nociceptors including TRPV1 (transient receptor potential vanilloid 1) to cause pain sensation (43) , at the cheek or forepaw also induced EAE relapse (42) . These results demonstrated that pain sensation is not simply an alert for the disease status or injury, but also a positive regulator of local inflammation at a remote site via specific neural pathways.
To identify the blood vessel gateway for immune cells during the pain-induced relapse, we examined the L5 cord of EAE mice under the remission phase (hereinafter referred to as EAE-recovered mice). Although EAE-recovered mice showed complete remission without any clinical signs in appearance, a high number of activated monocytes with high levels of major histocompatibility complex (MHC) class II from the periphery (MHC class II high monocytes) and not derived from microglia were present around the meninges of the L5 spinal cord. Interestingly, after pain induction, these cells accumulated at the ventral vessels of the L5 cord, followed by infiltration of pathogenic CD4 + T cells from the ventral vessels. Interestingly, removal of MHC class II high monocytes by clodronate liposome or neutralization of chemokine CX3CL1 before pain induction prevented not only the accumulation of the activated monocytes at the vessels, but also the infiltration of pathogenic CD4 + T cells and relapse of EAE, indicating a key role of MHC class II high monocytes (42) . In vitro data demonstrated that these monocytes produce CX3CL1 upon stimulation with norepinephrine (NE), express the CX3CL1 receptor CX3CR1 and have antigen-presenting ability, suggesting the following scheme: (i) sensory-sympathetic nerve interactions by pain induce NE secretion around the ventral vessels of the L5 cord, (ii) auto/paracrine actions of the CX3CL1-CX3CR1 axis in MHC class II high monocytes accumulate at the ventral vessels and (iii) activation of pathogenic CD4 + T cells by the MHC class II high monocytes, followed by EAE relapse (Fig. 3) . Because these monocytes persisted in the spinal cord for a long time (even 1 year), we hypothesized that survival factors for these cells could be novel targets for the treatment of MS relapse. Collectively, these findings indicate that the gateway for immune cells during pain sensation is the ventral blood vessels of the spinal cord (Fig. 3) . The gateway reflex by gravity or electric stimulation targeted the dorsal vessels of the spinal cord. Therefore, the gateway reflex by pain stimulation reveals distinct neural activation at different sites. Further experiments using gene knockout mice and chemical inhibitors defined a specific neural pathway that involves TRPV1/Nav1.8-positive sensory neurons, the anterior cingulate cortex, which is a pain-processing area in the brain, and sympathetic neurons that distribute to the ventral vessels of the spinal cord (Fig. 3) (42) . Blood corticosterone and catecholamine levels were elevated in mice with pain sensation, suggesting a systemic activation of sympathetic neurons. Indeed, pain induction in mice stimulates neural activations in L1 as well as L5 sympathetic ganglion, suggesting broader spinal cord levels are affected. Because L5 cord is the first inflammation site and contains higher numbers of MHC class II high monocytes even during the remission phase of EAE, the relapse response takes place mostly at L5 cord dependently on pathogenic CD4 + T cells in the blood (42) . Following the gravity and electric gateway reflexes, this pain gateway reflex is the third example of the gateway reflex.
A molecular basis for 'illness starts in the mind'
It is known that mental stresses deteriorate a pre-existing disease status and make one predisposed to gastrointestinal (44) and cardiovascular dysfunctions (45) . These phenomena are the roots of proverbs like 'illness starts in the mind' and 'care killed the cat', but the underlying molecular mechanisms remain undefined. Because mental stresses are perceived as neural stimulations in specific brain areas, including the paraventricular nucleus (PVN), dorsomedial nucleus of hypothalamus (DMH), dorsal motor nucleus of the vagal nerve (DMX) and the vagal nerve pathway (46) , and because MS has been associated with mental illnesses and gastrointestinal failures Fig. 3 . Pain gateway reflex. Sensory nerve stimulation by pain activates the anterior cingulate cortex (ACC), a pain-processing area in the brain. Subsequent activation of specific sympathetic nerves causes NE-dependent up-regulation of chemokine CX3CL1 expression around the ventral vessels of the spinal cord. Because MHC class II high monocytes reside within the L5 spinal cord, which is the initial inflammatory lesion of transfer EAE, this region is affected most after pain induction. NE induces the production of chemokine CX3CL1 from MHC class II high monocytes. CX3CL1 further recruits these cells around the ventral vessels. MHC class II high monocytes have a capacity to present myelin oligodendrocyte glycoprotein (MOG) antigens to pathogenic CD4 + T cells, causing disease relapse.
Neuro-immune interactions by the gateway reflex
(47-53), we pursued a proof-of-concept for the stress gateway reflex using the transfer EAE model. To examine the effect of stress conditions during transfer EAE, a sleep disorder model was employed, in which chronic stress can be imposed on mice reared on a free rotation wheel by the perpetual avoidance of water (54, 55) . To our surprise, the combination of sleep disorder and transfer EAE resulted in a high rate of sudden death of the mice (56) . Neither sleep disorder nor transfer EAE alone, however, induced death. Another chronic stress model, such as water in the bedding, which gives the mice discomfort, in combination with transfer EAE also increased the rate of sudden death, suggesting that chronic stress, not just sleep disturbance, is a determining factor. As mentioned earlier, transfer EAE develops from the L5 spinal cord because of the gravity gateway reflex (17) . However, stress plus pathogenic T-cell transfer in mice caused almost no immune cell accumulation at the L5 cord. Instead, donor pathogenic CD4 + T cells and periphery-derived MHC class II high monocytes during the early phase were found around blood vessels surrounded by the dentate gyrus (DG, a part of the hippocampus), thalamus and third ventricle (3V) in the brain. Because an essential element of the blood vessel gateway formation is chemokine induction, we neutralized various chemokines and found that anti-CCL5 antibody treatment suppressed the sudden death by transfer EAE under stress condition. Indeed, CCL5 expression in specific vessels of the boundary area of the DG, thalamus and 3V was induced by chronic stress alone but not by pathogenic T cells transfer (56) . Neural tracing experiments revealed a neural connection with tyrosine hydroxylase-positive noradrenergic nerves between the specific vessels and PVN. These results demonstrate that chronic stress can change the immune cell gateway from the L5 dorsal vessels to specific brain vessels by the induction of CCL5 via a specific neural pathway from the PVN to the vessels in the presence of stress, thus defining the fourth example of the gateway reflex, the stress gateway reflex (Fig. 4) (56) .
Immune cell infiltration at specific brain vessels could not directly explain the sudden death of EAE mice with stress. We further looked for neural connections from specific vessels adjacent to the DG, thalamus and 3V and found that there is a neural circuit from the vessels to the DMH, a hypothalamus region that is hyper-activated in mice with stress plus pathogenic T-cell transfer and communicates with the DMX (56) . In other words, a new neural pathway, specific vessels-DMH-DMX, is hyperactivated in mice with stress plus pathogenic T cells. To activate this pathway, a neurotransmitter is required. We identified this neurotransmitter as ATP (57), which can also act as a pro-inflammatory factor (58) . Intracranial injection of ATP or an antagonist for P2RX7, an ATP receptor, to blood vessels at the boundary area of the DG, thalamus and 3V induced mortality in stressed mice without transfer EAE or suppressed it with transfer EAE. Neural activation in the DMH was also significantly suppressed by P2RX7 antagonism at the specific vessels in mice with stress and pathogenic T cells. Cytokine injection around these vessels also caused sudden death in stressed mice (56) . Thus, micro-inflammation in the specific vessels adjacent to the DG, thalamus and 3V is sufficient to mimic the effect of transfer EAE under stress condition. Finally, we surgically blocked the vagal nerve pathway, whose hyper-activation is known to produce gastric acid and epithelial damage in the stomach (59, 60) . As expected, the vagotomy prevented mortality in EAE mice under Fig. 4 . Stress gateway reflex. Under a chronic stress condition, EAE mice develop severe gastrointestinal (GI) failure with high mortality. Chronic stress induces activation of the PVN, which in turn stimulates tyrosine hydroxylase (TH)+ neurons connecting to specific vessels surrounded by the third ventricle, thalamus and DG to cause micro-inflammation in the brain. This micro-inflammation activates an otherwise resting neural pathway to the DMH through the production of ATP. DMH signals transmit to the DMX to activate efferent vagal nerves and severe upper GI tract failure. Potassium ion levels in the blood increase with severe GI bleeding, which eventually induces heart failure associated with cardiac myocyte death. Experimental evidence showing that afferent vagal nerves prevented the fatal symptom also suggests an involvement of the afferent vagal nerve pathway for the stress gateway reflex (not shown in the figure).
stress. Therefore, the stress gateway reflex strongly enhances a stress response via the formation of a blood vessel gateway at specific blood vessels at the boundary of the DG, thalamus and 3V to activate a new neural circuit involving the DMH, DMX and vagal nerves. Enhanced activation of the vagal nerves in stressed EAE mice led to epithelial damage in the upper gastrointestinal tract and a subsequent increase in plasma potassium levels caused by gastrointestinal bleeding, which eventually led to heart failure ( Fig. 4) (56) . Blood aldosterone and cortisol levels were also elevated in mice with chronic stress, but these levels were not significantly changed between groups with or without pathogenic CD4 + T-cell transfer. Moreover, corticosteroid receptor antagonists, mifepristone and guggulsterone, had no effect on the phenotypes of the stress gateway reflex (56) . These results suggest that the stress gateway reflex enhances the specific stress responses systemically elicited by activating specific neural circuits via micro-inflammation at specific vessels. We also observed high levels of circulating troponin I and creatine kinase-MB, markers for the necrosis of cardiac myocytes, and the involvement of afferent vagal nerves in the sudden death, since desensitization of the afferent vagal nerves by capsaicin prevented the fatal symptom (unpublished data by Masaaki Murakami).
Micro-inflammation in the brain can modulate the function of organs in the periphery and maybe brain function itself by activating otherwise quiescent neurons. Neural activations generally require energy supply. It is reported that neural activity and cerebral blood flow are functionally coupled: increases of neural activity lead to increases of cerebral blood flow in highly restricted areas of neural activation by releasing substances such as NO, PGE2 and ATP, a phenomenon called neurovascular coupling (61) . This coupling is thought to reflect the lack of energy resources in the activated areas of the brain (61) . Since ATP mediates the stress gateway reflex (56) and neurovascular coupling in some cases (61, 62) , we propose that a mechanism similar to neurovascular coupling satisfies the additional energy demands upon the activation of new neural pathways by the stress gateway reflex.
Because stress can cause brain micro-inflammation if CNSreactive CD4 + T cells are present, this mechanism can be regarded as one molecular basis for 'illness starts in the mind'. Indeed, brain micro-inflammation is observed in pathological conditions such as Alzheimer's disease, non-Alzheimer-type dementia, Parkinson's disease, psychological disorder and epilepsy (63) (64) (65) (66) . Therefore, it could potentially activate new neural pathways to disturb brain function by establishing new neural networks and dysregulating existing ones and/or certain organ functions in the periphery, which is consistent with the stress gateway reflex.
Neuro-immune interactions with anti-inflammatory effects
The gateway reflex explains how specific neural activations change the status of specific blood vessels and have pro-inflammatory effects. On the other hand, neuro-immune interactions, which inhibit inflammatory responses, have also been reported. Kevin J. Tracey and his group demonstrated that vagal nerve stimulation inhibits endotoxin shock in mice, what they called the inflammatory reflex (3) (4) (5) (6) (7) . Pro-inflammatory cytokines and/or pathogen-associated molecular patterns stimulate afferent vagal nerves to activate efferent vagal nerves via brain stem nuclei. The efferent neural signals are transmitted to splenic nerves, releasing noradrenaline in the spleen. CD4 + T cells expressing β1/2 adrenaline receptor were shown to produce acetylcholine in response to noradrenaline, which suppressed the production of pro-inflammatory cytokines from macrophages in a manner dependent on α7 nicotinic acetylcholine receptor (Fig. 5) (3-7, 67) . It was recently reported that C1 Fig. 5 . Inflammatory reflex. After afferent and efferent vagal nerves are activated during septic shock or ischemic reperfusion injury, the production of NE from the splenic nerves is induced. NE stimulates the release of acetylcholine (ACh) from a subset of CD4 + T cells expressing β1/2 adrenaline receptor. ACh binds to α7 nicotinic acetylcholine receptor (α7nAChR)-positive macrophages to down-regulate the expression of pro-inflammatory cytokines including tumor necrosis factor α (TNFα). It is reported that C1 neurons in the brain mediate this cholinergic anti-inflammatory effect.
neurons, which are glutamatergic, catecholaminergic and peptidergic neurons in the medulla oblongata, can mediate the cholinergic anti-inflammatory effect in mice during ischemia-reperfusion injury (68, 69) . On the other hand, the responsible neural pathway(s) between efferent vagal and splenic nerves is still a matter of debate (70, 71) . The cholinergic anti-inflammatory effects can be manipulated artificially. Electro-acupuncture of mice at the ST36 Zusanli acupoint inhibited a septic shock response through vagal activation (72) . Furthermore, local ultrasound stimulated the anti-inflammatory splenic neuro-immune interaction in mice and improved kidney ischemia-reperfusion injury (73) . Interestingly, electric vagal stimulation in brain-dead animals also exerted anti-inflammatory effects, and a kidney graft from vagal-stimulated donor rats maintained significantly better long-term renal function in recipient rats (74) . The Tracey group developed a strategy to stimulate vagal nerves known as bioelectric medicine (75, 76) , which was found effective in patients with RA (77) . An implantable vagal nerve stimulator is also effective in Crohn's disease (78) . These translational researches hold promise for treating various inflammatory diseases by modulating specific neural activation to regulate immune responses.
Conclusion
To date, four types of gateway reflex have been reported. We are investigating new types of gateway reflex, including light-mediated changes in eye pathology (light gateway reflex) and a local neural network to explain symmetrical inflammation (symmetrical gateway reflex). Recent advances in analytic technologies including tissue clearing reagents such as CUBIC, PACT, Scale and CLARITY (79) (80) (81) (82) (83) (84) , transgenic mice for the study of neural activations including Arc-dVenus, GCaMP and cFos-GFP mice (85) (86) (87) , opto/chemogenetics (88, 89) , various viral and chemical tracers (90) , and neuron mapping with an RNA barcoding system (91) are expected to facilitate the identification of more neural pathways in the gateway reflex. Because neural circuits are distributed throughout the body, identifying tissue-specific, local neuro-immune interactions should contribute to novel therapies, similar to the inflammatory reflex (77, 78) .
In this article, we mainly summarized recent findings about the gateway reflex. The discovery of the stress gateway reflex (56) extended this research field to one that not only investigates neural regulation of the immune system, but also enables unexpected organ function as a consequence of interplay between the nervous and immune systems.
